[go: up one dir, main page]

GR78931B - - Google Patents

Info

Publication number
GR78931B
GR78931B GR72254A GR830172254A GR78931B GR 78931 B GR78931 B GR 78931B GR 72254 A GR72254 A GR 72254A GR 830172254 A GR830172254 A GR 830172254A GR 78931 B GR78931 B GR 78931B
Authority
GR
Greece
Application number
GR72254A
Other languages
Greek (el)
Inventor
Nicola Green
Stephen Alexander
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of GR78931B publication Critical patent/GR78931B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K16/108—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR72254A 1982-08-23 1983-08-19 GR78931B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41045582A 1982-08-23 1982-08-23

Publications (1)

Publication Number Publication Date
GR78931B true GR78931B (fr) 1984-10-02

Family

ID=23624803

Family Applications (1)

Application Number Title Priority Date Filing Date
GR72254A GR78931B (fr) 1982-08-23 1983-08-19

Country Status (16)

Country Link
EP (1) EP0116629A4 (fr)
JP (1) JPS59501714A (fr)
KR (1) KR840006198A (fr)
AU (1) AU570929B2 (fr)
DK (1) DK203684D0 (fr)
ES (1) ES525088A0 (fr)
FI (1) FI841583L (fr)
GR (1) GR78931B (fr)
IL (1) IL69556A (fr)
IT (1) IT1168636B (fr)
NO (1) NO161002C (fr)
NZ (2) NZ220612A (fr)
PH (1) PH18872A (fr)
PT (1) PT77230B (fr)
WO (1) WO1984000687A1 (fr)
ZA (1) ZA836080B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR241713A1 (es) * 1984-08-30 1992-11-30 Smithkline Beckman Corp Molecula de dna con una secuencia de bases que codifica la proteina c13 y preparacion de vacunas contra la gripe.
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
WO1990008161A1 (fr) * 1989-01-12 1990-07-26 The Blood Center Of Southeastern Wisconsin Modulation par peptides mediateurs de la reconnaissance d'antigenes par les lymphocytes t, utilises comme moyens d'affectation de reactions immunitaires
EP0621339B1 (fr) * 1992-09-17 2001-10-24 Takara Shuzo Co. Ltd. Polypeptides immunogès dérivées du haemagglutinen de virus de la influenza type A humain
JP2996864B2 (ja) * 1994-03-30 2000-01-11 寳酒造株式会社 抗体可変領域ｄｎａ
US8148085B2 (en) 2006-05-15 2012-04-03 Sea Lane Biotechnologies, Llc Donor specific antibody libraries
CN103435697A (zh) * 2006-05-15 2013-12-11 航道生物技术有限责任公司 流感病毒的中和抗体
HRP20130163T1 (hr) * 2006-09-07 2013-03-31 Crucell Holland B.V. Ljudske molekule za vezanje koje mogu neutralizirati virus influence h5n1 i njihova uporaba
ITTO20070066A1 (it) 2007-01-30 2008-07-31 Pomona Biotechnologies Llc Anticorpi monoclonali anti-idiotipo mimotopi dell'antigene gp 120 di hiv
WO2008118970A2 (fr) 2007-03-27 2008-10-02 Sea Lane Biotechnologies, Llc Constructions et bibliothèques comprenant des séquences de chaînes légères de substitution d'anticorps
ITTO20080204A1 (it) 2008-03-17 2009-09-18 Pomona Biotechnologies Llc Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
US20100040635A1 (en) 2008-03-28 2010-02-18 Sea Lane Biotechnologies Neutralizing antibodies to influenza viruses
ITTO20080398A1 (it) 2008-05-27 2009-11-28 Pomona Biotechnologies Llc Anticorpi monoclonali aventi proprieta' di cross-neutralizzazione omosubtipica per virus influenzali di tipo a sottotipo h1
ITTO20080964A1 (it) 2008-12-22 2010-06-23 Natimab Therapeutics S R L Anticorpo monoclonale anti-hcv come medicamento per il trattamento terapeutico e la prevenzione di infezioni da hcv
EP2380976A4 (fr) 2008-12-25 2012-11-07 Univ Osaka Anticorps humain anti-virus de la grippe humaine
EP2413962A1 (fr) 2009-03-30 2012-02-08 Mount Sinai School of Medicine Vaccins pour le virus influenza et leurs utilisations
WO2010132604A2 (fr) 2009-05-13 2010-11-18 Sea Lane Biotechnologies, Llc Molécules neutralisantes dirigées contre les virus de la grippe
EP2435475B1 (fr) 2009-05-26 2018-10-17 Icahn School of Medicine at Mount Sinai Anticorps monoclonaux dirigés contre le virus de la grippe, générés par administration cyclique, et leurs utilisations
IT1395961B1 (it) 2009-06-01 2012-11-02 Pomona Biotechnologies Llc Anticorpi monoclonali come medicamento per il trattamento terapeutico e/o profilattico delle infezioni da virus influenzale a (h1n1) di origine suina (s-oiv)
CN102939096B (zh) * 2010-02-18 2016-03-02 西奈山医学院 用于预防和治疗流感病毒疾病的疫苗
US9708373B2 (en) 2010-03-30 2017-07-18 Icahn School Of Medicine At Mount Sinai Influenza virus vaccine and uses thereof
WO2013016714A1 (fr) 2011-07-28 2013-01-31 Sea Lane Biotechnologies Protéines se liant à sur dirigées contre erbb3
ES2953393T3 (es) 2011-09-20 2023-11-10 Icahn School Med Mount Sinai Vacunas contra el virus de la influenza y sus usos
EP2793940B1 (fr) 2011-12-22 2018-11-14 i2 Pharmaceuticals, Inc. Protéines substitutives de liaison
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
CN108641002A (zh) 2012-12-18 2018-10-12 西奈山伊坎医学院 流感病毒疫苗及其用途
WO2014159960A1 (fr) 2013-03-14 2014-10-02 Icahn School Of Medicine At Mount Sinai Anticorps contre l'hémagglutinine du virus de la grippe et utilisations correspondantes
EP3247389A4 (fr) 2015-01-23 2019-10-30 Icahn School of Medicine at Mount Sinai Régimes de vaccination contre le virus de la grippe
WO2017083627A1 (fr) 2015-11-13 2017-05-18 Visterra, Inc. Compositions et méthodes pour traiter et prévenir la grippe
CN109195629A (zh) 2016-02-24 2019-01-11 威特拉公司 流行性感冒抗体分子制剂
JP7237344B2 (ja) 2016-06-15 2023-03-13 アイカーン スクール オブ メディシン アット マウント サイナイ インフルエンザウイルス血球凝集素タンパク質及びその使用
US11254733B2 (en) 2017-04-07 2022-02-22 Icahn School Of Medicine At Mount Sinai Anti-influenza B virus neuraminidase antibodies and uses thereof
EP3810634A4 (fr) 2018-06-21 2022-07-27 Icahn School of Medicine at Mount Sinai Polypeptides d'hémagglutinines du virus de la grippe en mosaïque et leurs utilisations
JP2022521819A (ja) 2019-03-25 2022-04-12 ビステラ， インコーポレイテッド インフルエンザを処置および予防するための組成物および方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI83662C (fi) * 1980-07-17 1991-08-12 Scripps Clinic Res Diagnostik antikropp och foerfarande foer dess framstaellning.

Also Published As

Publication number Publication date
NZ220612A (en) 1988-07-28
IT8348868A0 (it) 1983-08-22
ES8505819A1 (es) 1985-06-16
IT1168636B (it) 1987-05-20
ZA836080B (en) 1984-04-25
IT8348868A1 (it) 1985-02-22
AU570929B2 (en) 1988-03-31
NO161002C (no) 1989-06-21
IL69556A (en) 1988-05-31
EP0116629A4 (fr) 1987-06-29
PT77230B (en) 1986-02-04
ES525088A0 (es) 1985-06-16
AU1947183A (en) 1984-03-07
NO841540L (no) 1984-04-17
KR840006198A (ko) 1984-11-22
WO1984000687A1 (fr) 1984-03-01
JPS59501714A (ja) 1984-10-11
NO161002B (no) 1989-03-13
PT77230A (en) 1983-09-01
EP0116629A1 (fr) 1984-08-29
NZ205341A (en) 1988-07-28
PH18872A (en) 1985-10-21
DK203684A (da) 1984-04-18
FI841583A0 (fi) 1984-04-19
IL69556A0 (en) 1983-11-30
FI841583A7 (fi) 1984-04-19
FI841583L (fi) 1984-04-19
DK203684D0 (da) 1984-04-18

Similar Documents

Publication Publication Date Title
DE3347807A1 (fr)
DK8504588A (fr)
CH655656B (fr)
FR2519617B3 (fr)
DE3278104D1 (fr)
CH655594B (fr)
DE3348027A1 (fr)
GR78931B (fr)
FR2520145B1 (fr)
FR2520076B1 (fr)
DE3347867A1 (fr)
DE3348339A1 (fr)
CH655565B (fr)
CH655521B (fr)
FR2519861B1 (fr)
FR2520570B1 (fr)
DK350783D0 (fr)
FR2519402B1 (fr)
FR2519941B3 (fr)
FR2520063B3 (fr)
CH655626B (fr)
CH669703GA3 (fr)
FR2520153B3 (fr)
FR2519894B1 (fr)
FR2519579B1 (fr)